Cellular Immunology
A section of Cells (ISSN 2073-4409).
Section Information
The immune system plays a key role in protecting the host from microbes and chemicals preserving the homeostasis of the body. Also, it is involved in sensing danger signals originating from the host components during disease onset and progression as well as repair of tissues. Thus, the immune system can greatly influence the overall physiological and pathophysiological responses. Cells of the innate and adaptive immunity can interact with cellular and matrix components of several tissues and this interaction is strictly regulated. This section of Cells aims to publish findings that provide novel insights and/or conceptual advances to the knowledge of phenotypic, biochemical and molecular features and functional mechanisms of immune cells. Relevant research topics include, but are not limited to, the following:
- innate immunity
- adaptive immunity
- bridge between innate and adaptive immunity
- cross-talk between immune cells and tissue microenvironment
- immunobiology and immunogenetics
- tumor immunology
- cells in immune-mediated diseases
- immunopharmacology
- infection immunology
- neuroimmunology
- transplantation immunology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Role of Extracellular Vesicles in Inflammatory Diseases (Deadline: 30 April 2024)
- Macrophage Activation and Regulation (Deadline: 30 April 2024)
- Graft versus Host Disease (GVHD) after Hematopoietic Cell Transplantation (Deadline: 30 April 2024)
- Lipids, Lipoproteins and Lipid-Targeting Therapies in the Regulation of Immune Function and Inflammation (Deadline: 30 April 2024)
- Formation, Aggregation, Persistence, and Maturation of NETs (Deadline: 15 May 2024)
- Role of Inflammasome Activation in Innate and Adaptive Immunity (Deadline: 15 May 2024)
- Advances in the Study of Natural Killer (NK) Cells (Deadline: 30 May 2024)
- Role of Innate Immunity in Chronic Kidney Diseases—Series 2 (Deadline: 30 May 2024)
- T-Cell Acute Lymphoblastic Leukaemia (Deadline: 31 May 2024)
- Cancer Stem Cells and Immunotherapy (Deadline: 31 May 2024)
- The Pathogenetic Triad of Chronic Airway Diseases—Inflammation, Tissue Destruction, and Airway Remodeling (Deadline: 31 May 2024)
- Melanoma and Non-melanoma Skin Cancer: Cellular Mechanisms, Immunity and Therapeutics (Deadline: 15 June 2024)
- Progress in Cancer Immunotherapies (Deadline: 20 June 2024)
- Innate Cellular Immunity in Xenotransplantation (Deadline: 27 June 2024)
- Insights That—unlike Serum Antibodies—Memory B Cells Can Provide (Deadline: 30 June 2024)
- The Role of Macrophages and Neutrophils in Chronic Inflammation-Related Disorders (Deadline: 10 July 2024)
- Immunopharmacology: Current Applications and Future Perspectives (Deadline: 31 July 2024)
- New Developments in Rheumatoid Arthritis (Deadline: 31 July 2024)
- Inflammation in Target Organs (Deadline: 29 August 2024)
- Regulatory T Cells and Autoimmunity (Deadline: 30 August 2024)
- Human Inborn Errors of Immunity (Deadline: 31 August 2024)
- Mucosal Immunity and Epithelial Barrier Biology: From Tissue Homeostasis to Chronic Disease (Deadline: 20 September 2024)
- Harnessing the Immune System to Fight Pediatric Cancer—Second Edition (Deadline: 20 September 2024)
- Synaptic Dysfunction in the Progressive Neurodegeneration of Alzheimer’s Disease and Related Dementia (Deadline: 30 September 2024)
- Advances in Cellular and Molecular Treatment of Autoimmune Diseases (Deadline: 30 September 2024)
- Molecular Insights into Corneal Wound Healing and Inflammation (Deadline: 30 September 2024)
- Allergic Airway Disease: Immunology, Pathogenesis, Inflammation (Deadline: 1 October 2024)
- Hypoxia Pathway Proteins in the Immune System: Regulation, Disease, and Therapeutics (Deadline: 15 October 2024)
- Stroke Immunology: Mechanisms and Therapeutic Prospects (Deadline: 15 October 2024)
- Immune Functions and Therapeutic Potential of B Lymphocytes in Autoimmune Disorders (Deadline: 20 October 2024)
- Advancements in Cellular Immunotherapies in the Immune Checkpoint Inhibitor Era for Cancer Treatment (Deadline: 31 October 2024)
- The Role of Inflammation in AMD (Multifactorial Age-Related Macular Degeneration)—Volume II (Deadline: 31 October 2024)
- Immunopathogenesis and Therapies of Granulomatous Diseases (Deadline: 31 October 2024)
- Onco-Hematology and Immunotherapy (Deadline: 31 October 2024)
- Natural Products and Their Derivatives in Immunity (Deadline: 25 November 2024)
- Potential of CAR-Based Cellular Immunotherapy for Non-oncologic Disorders (Deadline: 31 December 2024)
- Cancer Immunotherapy Harnessing Innate and Adaptive Immune Effector Cells and PD-1 Immune Checkpoint Inhibitors (Deadline: 31 December 2024)
- The Role of IgE and IgG Antibodies in Allergic Reactions: Cellular Mechanisms and Biological Implications (Deadline: 31 December 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Advances in Immune Monitoring (Closed)
- Allergy, Asthma and Clinical Immunology
- Cellular Immunology and COVID-19
- Emerging Roles of Neutrophil in Inflammation and Immunity
- Feature Papers in ‘Cellular Immunology’
- Gut Microbiota-Derived Metabolites and Host Gut-Brain Communication
- Immuno-Metabolic Crosstalk in Oncogenesis
- Mast Cells in Health and Diseases
- Novel Advances in Cancer Immunology: From Molecular Mechanisms to Therapeutic Applications
- The Increasingly Fascinating World of Interleukins
- The New Era of Mesenchymal Stromal/Stem Cell Functional Application: State of the Art, Therapeutic Challenges and Future Directions
- Trends and Advances in Tumor Immunology
